Treatment of Telangiectasias with the 532-nm and the 532/940-nm Diode Laser

ABSTRACT

Recently, a dual-wavelength 532/940-nm laser has become available for treatment of facial vascular lesions as an alternative to the flashlamp pumped-dye lasers. Most facial vascular lesions will respond to the 532-nm wavelength. However, some of the larger and deeper lesions are resistant to this laser. The 940-nm wavelength can be used to treat these resistant lesions. Sixteen patients with 532-nm laser-resistant vascular lesions were treated with the 940-nm laser. Fourteen of these 16 patients had improvement in their telangiectasia in response to these treatments. Most facial l telangiectasias respond well to treatment with the 532-nm laser. However, some of the larger and deeper lesions will not respond well to this laser. The 940-nm wavelength laser can be used to treat these 532-nm laser resistant lesions.

KEYWORDS

Vascular laser - telangectasias - 532/940-nm laser - vasular lesions

REFERENCES

• 1 Broska P, Martinho E, Goodman M M. Comparison of the argon tunable dye laser with the flashlamp pulsed dye laser in treatment of facial telangiectasia.  J Dermatol Surg Oncol. 1994;  20 749-753
• 2 Cassuto D, Ancona D, Emanuelli G. Treatment of facial telangiectasias with a diode-pumped Nd:YAG laser at 532 nm.  J Cutan Laser Ther. 2000;  2 141-146
• 3 Shamma A R, Ramadan F M, Vonderlieth K. Transdermal laser treatment of facial telangiectasia-comparison of the 532 nm KTP to the 940 nm diode wavelength. Proceedings of the International Vein Congress.  2004; 
• 4 Kauvar A NB, Fre K E, Friedman P M, Geronemus R G. Cooling gel improves pulsed KTP laser treatment of facial telangiectasia.  Lasers Surg Med. 2002;  30 149-153